person
Sergio B.
- Country
- Italy
- Department
- S.C. Oncologia
Research Overview
assignment
14
Clinical Trials ·
- A Phase 3, Randomized, Double-blind Trial of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (KEYNOTE-641)
- A Phase 2 Multi-Cohort, Open-Label, Multi-Center Clinical Study Evaluating the Efficacy and Safety of Disitamab Vedotin (RC48-ADC) Alone and in Combination with Pembrolizumab in Subjects with Locally Advanced Unresectable or Metastatic Urothelial Carcinoma That Expresses HER2
- A Phase 3, Randomized, Double-blind Study to Evaluate Perioperative Pembrolizumab (MK-3475) + Neoadjuvant Chemotherapy versus Perioperative Placebo + Neoadjuvant Chemotherapy in Cisplatin-eligible Participants with Muscle-invasive Bladder Cancer (KEYNOTE-866)
location_city
2
Research Sites
Data & Insights
medical_services
Primary Speciality
Main therapeutic area
handshake
Return Partnerships
Recurring site collaborations
109
Sites with multiple studies
Has run more than one trial at 109 of 256 partner sites.
Specializations
Urological Oncology
Specializes in innovative treatments for urothelial carcinoma and bladder cancer, with particular focus on immunotherapy combinations and targeted therapies.
- Advanced/Metastatic Urothelial Cancer
- Muscle-Invasive Bladder Cancer
- HER2-Expressing Urothelial Tumors
Genitourinary Cancers
Conducts extensive research in prostate cancer and renal cell carcinoma treatment approaches, focusing on novel therapeutic combinations.
- Metastatic Castration-Resistant Prostate Cancer
- Advanced Renal Cell Carcinoma
- Oligometastatic Kidney Cancer
Thoracic Oncology
Investigates treatments for non-small cell lung cancer and small cell lung cancer, with emphasis on targeted and immunological approaches.
- Advanced Non-Squamous NSCLC
- EGFR-Mutated Lung Cancer
- Limited Stage Small-Cell Lung Cancer
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.